secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-10-05T12:45:07+00:00
Accession:  0001193125-26-413233
Event type: dividend
Sentiment:  negative
Materiality: 0.95
Item codes: 1.01, 2.03, 3.03, 8.01, 5.03, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Jaguar Health declares Series R preferred dividend, amends royalty and note obligations
--------------------------------------------------------------------------------

- Board declared special one-time dividend of one Series R Convertible Preferred share per common share; record date Oct 13, 2026, payment date Oct 15, 2026.
- Series R designates 2,325,000 preferred shares; each converts into 5 common shares on Nov 2, 2026, up to 11,625,000 conversion shares.
- Example: 2,281,247 Series R shares would yield 11,406,235 common shares, about 83.3% of outstanding common stock after conversion.
- Uptown and Streeterville royalty amendments extend monthly payments from Oct 1, 2026 to Jan 1, 2027; monthly Royalty Payment is greater of $750,000 or actual amount.
- 2021 Note maturity extended from Oct 1, 2026 to Jan 1, 2027; C/M Capital consented to dividend and Series R authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526413233/0001193125-26-413233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526413233/d183888d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-413233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer